Concepedia

Samit Hirawat

SH

Statistics

Publications

27

Citations

9.4K

H-Index

21

Active since

2001

Affiliations

PTC Therapeutics (United States)(Current)

Novartis (Switzerland)

Novartis (United States)

The University of Texas MD Anderson Cancer Center

Institut Gustave Roussy

Samit Hirawat is an author at PTC Therapeutics (United States) specializing in medicine, pharmacology, and oncology.

Publications per year

2001–2020

27

Publications

27

Alpelisib for <i>PIK3CA</i> -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

Fabrice André, Eva Ciruelos, Gábor Rubovszky et al. · New England Journal of Medicine · 2019 · 2.6K citations · Full text

, , +17

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer

Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris et al. · New England Journal of Medicine · 2016 · 2K citations · Full text

, , +17

PTC124 targets genetic disorders caused by nonsense mutations

Ellen Welch, Elisabeth R. Barton, Jin Zhuo et al. · Nature · 2007 · 1.1K citations

, , +8

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Debu Tripathy, Seock‐Ah Im, Marco Colleoni et al. · The Lancet Oncology · 2018 · 1K citations

, , +16

The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy

Craig M. McDonald, Erik Henricson, Jay J. Han et al. · Muscle & Nerve · 2009 · 390 citations

, , +17

1–5 of 27